Published in Am J Public Health on May 01, 1980
Factors influencing early diagnosis of cancer of the oral cavity. CMAJ (1985) 0.99
Cancer symptoms, clinical stage, and survival rates. Am J Public Health (1980) 0.87
The changing system of cancer staging. Am J Public Health (1980) 0.75
Growth rates of primary breast cancers. Cancer (1979) 1.80
New England prototype network demonstration project in breast cancer. Cancer (1978) 1.24
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell (1998) 17.76
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev (1999) 6.93
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A (2000) 3.95
Solubilization and partial purification of tyrosine hydroxylase from bovine adrenal medulla. J Biol Chem (1971) 2.85
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol (1999) 2.78
Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med (2000) 2.20
Phenylketonuria due to a deficiency of dihydropteridine reductase. N Engl J Med (1975) 2.18
3,4-dihydroxyphenylethylamine beta-hydroxylase. Physical properties, copper content, and role of copper in the catalytic acttivity. J Biol Chem (1965) 2.13
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol (2000) 2.12
The isolation and characterization of dihydropteridine reductase from sheep liver. J Biol Chem (1972) 2.02
Budd-Chiari syndrome: etiology, diagnosis and management. Medicine (Baltimore) (1982) 1.92
Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res (2000) 1.88
Widespread outbreaks of clam- and oyster-associated gastroenteritis. Role of Norwalk virus. N Engl J Med (1986) 1.82
Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria. N Engl J Med (1978) 1.71
Clinical hypertension and its interaction with diabetes among American Indians and Alaska Natives. Estimated rates from ambulatory care data. Diabetes Care (1993) 1.70
Purification and some physical properties of phenylalanine hydroxylase from rat liver. J Biol Chem (1970) 1.69
NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut (2007) 1.66
Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain. J Biol Chem (1972) 1.53
Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest (1994) 1.46
In vitro activation of rat liver phenylalanine hydroxylase by phosphorylation. J Biol Chem (1976) 1.45
Malignant hyperphenylalaninaemia--current status (June 1977). J Inherit Metab Dis (1978) 1.45
A protein that stimulates rat liver phenylalanine hydroxylase. J Biol Chem (1970) 1.41
Interferon-alpha-2b with VMCP for induction in multiple myeloma: the Israel Myeloma Cooperative Group experience. Isr J Med Sci (1995) 1.38
Identity of 4a-carbinolamine dehydratase, a component of the phenylalanine hydroxylation system, and DCoH, a transregulator of homeodomain proteins. Proc Natl Acad Sci U S A (1992) 1.36
K-Sol corneal preservation. Am J Ophthalmol (1985) 1.36
Characterization of the human granulocyte-macrophage colony-stimulating factor receptor. J Biol Chem (1988) 1.35
The development and function of gamma delta T cells. Immunol Today (1990) 1.33
In vitro model for stretch-induced hypertrophy of skeletal muscle. Science (1979) 1.33
Isolation and expression of rat liver sepiapterin reductase cDNA. Proc Natl Acad Sci U S A (1990) 1.31
Tetrahydrobiopterin, a cofactor for rat cerebellar nitric oxide synthase, does not function as a reactant in the oxygenation of arginine. Proc Natl Acad Sci U S A (1991) 1.30
The stimulation of rat liver phenylalanine hydroxylase by lysolecithin and -chymotrypsin. J Biol Chem (1973) 1.27
The phenylalanine hydroxylating system from mammalian liver. Adv Enzymol Relat Areas Mol Biol (1971) 1.26
Tetrahydrobiopterin, the cofactor for aromatic amino acid hydroxylases, is synthesized by and regulates proliferation of erythroid cells. Proc Natl Acad Sci U S A (1989) 1.25
Enhanced protein synthesis in a cell-free system from hypertrophied skeletal muscle. Science (1967) 1.23
Glucagon stimulation of rat hepatic phenylalanine hydroxylase through phosphorylation in vivo. J Biol Chem (1978) 1.22
Proteolytic modification of the amino-terminal and carboxyl-terminal regions of rat hepatic phenylalanine hydroxylase. J Biol Chem (1986) 1.19
Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J Immunol (1994) 1.19
Effect of jogging on serum low density lipoprotein cholesterol. Artery (1980) 1.18
Surgical approach to short-bowel syndrome. Experience in a population of 160 patients. Ann Surg (1995) 1.17
Chronic, nonocclusive, and maintenance-free central venous cannula in the rat. Am J Physiol (1980) 1.17
Glycolysis in chick embryo cell cultures transformed by Rous sarcoma virus. Cancer Res (1968) 1.17
Purification and characterization of phenylalanine hydroxylase-stimulating protein from rat liver. J Biol Chem (1973) 1.16
Atypical phenylketonuria with normal phenylalanine hydroxylase and dihydropteridine reductase activity in vitro. Pediatrics (1977) 1.16
Osteoblast precursor cells are found in CD34+ cells from human bone marrow. Stem Cells (1997) 1.16
Chondroitin sulfate in a new cornea preservation medium. Am J Ophthalmol (1984) 1.15
Metabolism of the phenylalanine hydroxylation cofactor. J Biol Chem (1967) 1.14
Conversion of 6-substituted tetrahydropterins to 7-isomers via phenylalanine hydroxylase-generated intermediates. Proc Natl Acad Sci U S A (1991) 1.13
Rat liver phenylalanine hydroxylase, an iron enzyme. J Biol Chem (1972) 1.13
Virilizing ovarian tumor in a 2 1/2-year-old girl. J Pediatr (1967) 1.12
Letter: New forms of phenylketonuria. Lancet (1975) 1.12
Carcinocythemia (carcinoma cell leukemia). An acute leukemia-like picture due to metastatic carcinoma cells. Am J Med (1976) 1.12
Sclerosing cholangitis. Anatomical distribution of obstructive lesions. Ann Surg (1984) 1.12
The activation of rat liver phenylalanine hydroxylase by limited proteolysis, lysolecithin, and tocopherol phosphate. Changes in conformation and catalytic properties. J Biol Chem (1984) 1.12
Structure and expression of human dihydropteridine reductase. Proc Natl Acad Sci U S A (1987) 1.11
Alpha 7 beta 1 integrin is a component of the myotendinous junction on skeletal muscle. J Cell Sci (1993) 1.11
Mutation in the 4a-carbinolamine dehydratase gene leads to mild hyperphenylalaninemia with defective cofactor metabolism. Am J Hum Genet (1993) 1.10
Prevalence of diagnosed diabetes among American Indians and Alaska Natives, 1987. Estimates from a national outpatient data base. Diabetes Care (1993) 1.10
Effects of acute hypertrophy on the contractile properties of skeletal muscle. Am J Physiol (1968) 1.09
E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes. Mol Cell Biol (1996) 1.09
Detection of hepatic phenylalanine 4-hydroxylase in classical phenylketonuria. Proc Natl Acad Sci U S A (1973) 1.08
Old age, rehabilitation, and research: a review of the issues. Gerontologist (1988) 1.08
Rat liver phenylalanine hydroxylase. Activation by sulfhydryl modification. J Biol Chem (1981) 1.08
Mendelian hyperphenylalaninemia. Annu Rev Genet (1988) 1.07
Bovine adrenal tyrosine hydroxylase: purification and properties. J Biol Chem (1977) 1.07
Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. J Cell Biochem (1999) 1.07
Studies on the mechanisms of action of phenylalanine hydroxylase and its protein stimulator. I. Enzyme concentration dependence of the specific activity of phenylalanine hydroxylase due to a nonenzymatic step. J Biol Chem (1973) 1.07
The role of young children in a community-wide outbreak of hepatitis A. Epidemiol Infect (1997) 1.06
Spectroscopic investigation of ligand interaction with hepatic phenylalanine hydroxylase: evidence for a conformational change associated with activation. Biochemistry (1984) 1.06
Phenylalanine 4-monooxygenase from rat liver. Methods Enzymol (1987) 1.05
The auto-oxidation of tetrahydrobiopterin. Eur J Biochem (1988) 1.05
Determination of the phosphate content of purified proteins. Anal Biochem (1982) 1.05
5-Fluorouracil in the treatment of gastrointestinal neoplasia. N Engl J Med (1973) 1.04
Clinical and biochemical observations of patients with atypical phenylketonuria. Pediatrics (1970) 1.03
Massive hemolysis caused by acetaminophen. Positive determination by direct Coombs test. JAMA (1976) 1.03
Distribution of 4a-hydroxytetrahydropterin dehydratase in rat tissues. Comparison with the aromatic amino acid hydroxylases. FEBS Lett (1992) 1.01
Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome. Ann Neurol (1989) 1.01
Role of right atrial receptors in the control of drinking in the rat. J Physiol (1984) 1.01
The normal pattern of pulmonary venous flow on pulsed Doppler examination of the human fetus. J Am Soc Echocardiogr (1996) 1.01
Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice. Blood (1996) 1.00
Studies on the phenylalanine hydroxylase system in liver slices. J Biol Chem (1975) 1.00
Regulation of the activity of hepatic phenylalanine hydroxylase. Adv Enzyme Regul (1986) 1.00
The hyperphenylalaninemias of man and mouse. Annu Rev Genet (1994) 1.00
Dihydropteridine reductase may function in tetrahydrofolate metabolism. J Neurochem (1978) 1.00
Neopterin and biopterin levels in patients with atypical forms of phenylketonuria. J Neurochem (1980) 1.00
AIDS behind bars. Epidemiology of New York State prison inmate cases, 1980-1988. N Y State J Med (1990) 0.99
Cellular and extracellular dehydration, and angiotensin as stimuli to drinking in the common iguana Iguana iguana. J Physiol (1977) 0.99
Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin: evidence that peripherally administered tetrahydropterins enter the brain. Pediatrics (1982) 0.98
7-Tetrahydrobiopterin is an uncoupled cofactor for rat hepatic phenylalanine hydroxylase. FEBS Lett (1991) 0.98
Production of antibodies to rat liver phenylalanine hydroxylase. Cross-reactivity with other pterin-dependent hydroxylases. Mol Pharmacol (1972) 0.98
The stimulation of rat liver phenylalanine hydroxylase by phospholipids. J Biol Chem (1972) 0.98
So-called hairy polyps or teratoid tumors of the nasopharynx. Arch Otolaryngol (1978) 0.98
Vincristine neurotoxicity. Ann Intern Med (1974) 0.97
Resection and reconstruction of the carotid artery in metastatic squamous cell carcinoma. Am J Surg (1981) 0.96
Resistance of TNF/LT alpha double deficient mice to bleomycin-induced fibrosis. Int J Exp Pathol (1997) 0.96
Further studies of the role of Ser-16 in the regulation of the activity of phenylalanine hydroxylase. Proc Natl Acad Sci U S A (1995) 0.96
Evidence for the lack of direct phosphorylation of bovine caudate tyrosine hydroxylase following activation by exposure to enzymatic phosphorylating conditions. Biochem Biophys Res Commun (1975) 0.96
Studies on the phenylalanine hydroxylase system in vivo. An in vivo assay based on the liberation of deuterium or tritium into the body water from ring-labeled L-phenylalanine. J Biol Chem (1975) 0.95
An electron paramagnetic resonance study of 3,4-dihydroxyphenylethylamine beta-hydroxylase. J Biol Chem (1966) 0.95
Timed-kill curves for Cryptococcus neoformans isolated from patients with AIDS. Med Mycol (2000) 0.95